Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Gilead Sciences Inc. (GILD)

-NasdaqGS
101.38 Down 1.96(1.90%) Apr 17, 4:00PM EDT
|After Hours : 101.40 Up 0.02 (0.02%) Apr 17, 7:59PM EDT
Add to Portfolio
Prev Close:103.34
Open:102.30
Bid:101.20 x 300
Ask:101.44 x 100
1y Target Est:119.08
Beta:0.9
Next Earnings Date:30-Apr-15GILD Earnings announcement
Day's Range:100.61 - 102.81
52wk Range:69.40 - 116.83
Volume:9,896,452
Avg Vol (3m):11,904,200
Market Cap:151.00B
P/E (ttm):13.79
EPS (ttm):7.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 1.90%151.00B
GSKDown 0.61%113.76B
PFEDown 0.43%214.76B
RHHBYDown 1.53%N/A

Key Statistics

Forward P/E (1 yr):9.75
P/S (ttm):6.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :9.60
Quarterly EPS Est (Mar-15) :2.28
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback